In this context, understanding the mechanism regulating the expression of PD-L1 in breast cancer is important for defining potential targets or developing novel strategies to achieve more sensitive detection of PD-L1 expression and/or more precise prediction of patient response toward anti-PD therapies. Here, CD274 is linked to breast cancer.